Interpace Biosciences, Inc. Stock
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.790 USD | +2.29% |
|
+15.89% | +45.50% |
| Market Cap | 44.04M 38.28M 35.74M 32.81M 61.86M 4.2B 62.94M 421M 165M 2.09B 165M 162M 6.91B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 42.72M 37.13M 34.66M 31.82M 60M 4.07B 61.05M 409M 160M 2.03B 160M 157M 6.7B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.29% | ||
| 1 week | +15.89% | ||
| Current month | +18.00% | ||
| 1 month | +9.82% | ||
| 3 months | -15.57% | ||
| 6 months | -6.28% | ||
| Current year | +45.50% |
| 1 week | 1.43 |  | 1.79 |
| 1 month | 1.34 | | 1.79 |
| Current year | 1.03 | | 2.4 |
| 1 year | 0.77 | | 2.4 |
| 3 years | 0.44 | | 3.54 |
| 5 years | 0.44 | | 10.33 |
| 10 years | 0.44 | | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 01/12/2020 |
| Director of Finance/CFO | 34 | 21/04/2023 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 21/06/2016 |
Joseph Keegan
BRD | Director/Board Member | 73 | 01/01/2016 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 22/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/1/26 | Ampersand Management LLC
| Conversion | Company | 13,861,386 | 313.0013% | |
| 20/1/26 | 1315 Capital LLC
| Conversion | Company | 9,405,941 | 212.3938% | |
| 1/2/24 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.29% | +15.89% | +115.66% | -3.24% | 44.04M | |
| +0.97% | +4.78% | +100.89% | +522.95% | 38.72B | |
| -0.58% | +2.08% | +17.56% | +42.81% | 24.87B | |
| +1.14% | +0.36% | -19.20% | -35.22% | 7.55B | |
| +4.74% | +8.60% | +22.14% | +106.11% | 5.25B | |
| -0.58% | +4.66% | +21.90% | +60.80% | 3.33B | |
| +3.60% | +20.55% | +206.98% | -0.56% | 2.04B | |
| +4.22% | +12.09% | -33.21% | +832.14% | 2.01B | |
| -0.90% | +4.05% | -12.50% | -60.91% | 1.89B | |
| +0.76% | +4.48% | +21.28% | +7.94% | 1.85B | |
| Average | +1.57% | +5.73% | +44.15% | +147.28% | 8.76B | |
| Weighted average by Cap. | +0.80% | +4.18% | +54.40% | +267.07% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 40.78M 38.08M 34.95M 65.91M 4.47B 67.06M 449M 176M 2.23B 176M 172M 7.36B | 38.73M 33.66M 31.42M 28.85M 54.39M 3.69B 55.34M 371M 145M 1.84B 145M 142M 6.07B |
| Net income | 6.7M 5.82M 5.44M 4.99M 9.41M 639M 9.58M 64.12M 25.11M 319M 25.17M 24.62M 1.05B | 24.58M 21.36M 19.94M 18.31M 34.52M 2.34B 35.12M 235M 92.08M 1.17B 92.31M 90.26M 3.85B |
| Net Debt | 4.4M 3.82M 3.57M 3.27M 6.17M 419M 6.28M 42.05M 16.47M 209M 16.51M 16.14M 689M | -1.32M -1.15M -1.07M -985K -1.86M -126M -1.89M -12.65M -4.95M -62.84M -4.97M -4.86M -207M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/08/26 | US$1.590 | +4.81% | 1,901 |
| 31/07/26 | US$1.517 | +5.35% | 100 |
| 30/07/26 | US$1.440 | -7.20% | 411 |
| 29/07/26 | US$1.552 | -0.05% | 300 |
| 28/07/26 | US$1.553 | +0.51% | 1,700 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
